Cart (0 Items)
Your cart is currently empty.
View ProductsDenintuzumab Biosimilar – Anti-CD19 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Denintuzumab Biosimilar - Anti-CD19 mAb - Research Grade |
|---|---|
| Source | CAS 1399672-02-6 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Denintuzumab,SGN-19A,SGN-CD19A,hBU12-491,unconjugated:huBU12,CD19,anti-CD19 |
| Reference | PX-TA1348 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Denintuzumab Biosimilar - Anti-CD19 mAb - Research Grade
General information on Anti-CD19[Homo sapiens] (Denintuzumab) Monoclonal Antibody
Denintuzumab has been infestigated in the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors.
Related products
Antigen
CD19 Protein – Human CD19 recombinant protein
PX-P4004 210€
Antigen
CD19 Recombinant Protein
PX-P4077 310€
SIL
Reviews
Il n’y a pas encore d’avis.